siRNA-话题@MedSci

#siRNA#

30篇内容 | 2548人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2226137, encodeId=92bd222613e04, content=<a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a> <a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=GUT：香港大学袁孟峰团队报告了siRNA慢性乙型肝炎(CHB)感染患者中的治疗作用！, objectType=article, longId=843581, objectId=e5b5843581a9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240622/1719058467451_5579292.jpg, objectUrl=/article/show_article.do?id=e5b5843581a9, replyNumber=0, likeNumber=63, createdTime=2024-09-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e5b5843581a9, moduleTitle=GUT：香港大学袁孟峰团队报告了siRNA慢性乙型肝炎(CHB)感染患者中的治疗作用！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5b5843581a9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190321, encodeId=80012190321e9, content=<a href='/topic/show?id=bcd6889e9d5' target=_blank style='color:#2F92EE;'>#血友病#</a> <a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a> <a href='/topic/show?id=b9a7111e62eb' target=_blank style='color:#2F92EE;'>#血浆纤溶酶原#</a>, objectTitle=Sci Transl Med：革命性疗法：利用siRNA靶向减少血浆纤溶酶原，为血友病患者带来希望, objectType=article, longId=814949, objectId=cd5e81494972, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-conference-P42ZDP5.jpg, objectUrl=/article/show_article.do?id=cd5e81494972, replyNumber=0, likeNumber=114, createdTime=2024-03-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=cd5e81494972, moduleTitle=Sci Transl Med：革命性疗法：利用siRNA靶向减少血浆纤溶酶原，为血友病患者带来希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd5e81494972)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2188932, encodeId=d893218893217, content=<a href='/topic/show?id=edbd88e6e7' target=_blank style='color:#2F92EE;'>#HIV#</a> <a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a> <a href='/topic/show?id=cbcce745264' target=_blank style='color:#2F92EE;'>#纳米药物#</a>, objectTitle=J Control Release：携带siRNA的新型纳米药物有望治疗HIV感染, objectType=article, longId=814342, objectId=5ffd814342a6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240223/1708641779744_2185383.png, objectUrl=/article/show_article.do?id=5ffd814342a6, replyNumber=0, likeNumber=83, createdTime=2024-02-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2185301, encodeId=17a32185301d3, content=<a href='/topic/show?id=9f7198199df' target=_blank style='color:#2F92EE;'>#降脂药#</a> <a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a> <a href='/topic/show?id=593c10e5975' target=_blank style='color:#2F92EE;'>#LDL-C#</a>, objectTitle=新型长效降脂疗法，一次给药管半年！2024年共识：6条建议助力临床实践, objectType=article, longId=811849, objectId=37558118497c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-conference-P42ZDP5.jpg, objectUrl=/article/show_article.do?id=37558118497c, replyNumber=0, likeNumber=126, createdTime=2024-02-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=37558118497c, moduleTitle=新型长效降脂疗法，一次给药管半年！2024年共识：6条建议助力临床实践, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37558118497c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2181637, encodeId=9af2218163e8d, content=<a href='/topic/show?id=69da53614b0' target=_blank style='color:#2F92EE;'>#慢性粒细胞白血病#</a> <a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a> <a href='/topic/show?id=888e11009244' target=_blank style='color:#2F92EE;'>#BATF3#</a>, objectTitle=Mol Biol Rep：siRNA介导的下调BATF3通过下调c-Myc表达降低慢性粒细胞白血病细胞的增殖和诱导凋亡, objectType=article, longId=809441, objectId=24cc809441f1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221120/1669014277918_4754896.webp, objectUrl=/article/show_article.do?id=24cc809441f1, replyNumber=0, likeNumber=113, createdTime=2024-01-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=24cc809441f1, moduleTitle=Mol Biol Rep：siRNA介导的下调BATF3通过下调c-Myc表达降低慢性粒细胞白血病细胞的增殖和诱导凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24cc809441f1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1548213, encodeId=c8c91548213f5, content=<a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a>, objectTitle=FDA批准vutrisiran治疗成人遗传性转甲状腺素蛋白淀粉样变性伴多发性神经病（hATTR-PN），这是第5款siRNA药物, objectType=article, longId=729775, objectId=6f41e29775b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f41e29775b5, replyNumber=0, likeNumber=89, createdTime=2022-06-18, rootId=0, userName=12498ebem23暂无昵称, userId=271114029857, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f41e29775b5, moduleTitle=FDA批准vutrisiran治疗成人遗传性转甲状腺素蛋白淀粉样变性伴多发性神经病（hATTR-PN），这是第5款siRNA药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f41e29775b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548212, encodeId=f33b1548212ee, content=<a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a>, objectTitle=JAMA：这一增加6成中风风险的坏“血脂”，终于有针对它的siRNA可以用了！, objectType=article, longId=723592, objectId=5f34e2359218, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f34e2359218, replyNumber=0, likeNumber=89, createdTime=2022-04-07, rootId=0, userName=12498ebem23暂无昵称, userId=271114029857, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f34e2359218, moduleTitle=JAMA：这一增加6成中风风险的坏“血脂”，终于有针对它的siRNA可以用了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f34e2359218)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548211, encodeId=3e67154821190, content=<a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a>, objectTitle=EHJ重磅：siRNA皮下注射有望长效降脂，长命百岁将不再是梦！, objectType=article, longId=301023, objectId=9b6430102313, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b6430102313, replyNumber=0, likeNumber=117, createdTime=2022-03-19, rootId=0, userName=12498ebem23暂无昵称, userId=271114029857, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b6430102313, moduleTitle=EHJ重磅：siRNA皮下注射有望长效降脂，长命百岁将不再是梦！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b6430102313)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548210, encodeId=421d1548210df, content=<a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a>, objectTitle=STTT：治愈乙肝新希望：新型纳米载体，递送siRNA特异性靶向肝细胞, objectType=article, longId=299378, objectId=64612993e804, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64612993e804, replyNumber=0, likeNumber=108, createdTime=2022-02-23, rootId=0, userName=12498ebem23暂无昵称, userId=271114029857, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64612993e804, moduleTitle=STTT：治愈乙肝新希望：新型纳米载体，递送siRNA特异性靶向肝细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64612993e804)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548209, encodeId=4e681548209d9, content=<a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a>, objectTitle=今日探报 | 诺华长效降脂siRNA疗法获FDA批准上市；研究表明，利用一滴血或许就能快速检测出早期肺癌……, objectType=article, longId=292887, objectId=627029288e90, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=627029288e90, replyNumber=0, likeNumber=92, createdTime=2021-12-29, rootId=0, userName=12498ebem23暂无昵称, userId=271114029857, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=627029288e90, moduleTitle=今日探报 | 诺华长效降脂siRNA疗法获FDA批准上市；研究表明，利用一滴血或许就能快速检测出早期肺癌……, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=627029288e90)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548208, encodeId=48f01548208b8, content=<a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a>, objectTitle=美国FDA延迟批准诺华的siRNA药物inclisiran, objectType=article, longId=204702, objectId=1eb3204e028a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1eb3204e028a, replyNumber=0, likeNumber=99, createdTime=2020-12-21, rootId=0, userName=12498ebem23暂无昵称, userId=271114029857, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1eb3204e028a, moduleTitle=美国FDA延迟批准诺华的siRNA药物inclisiran, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1eb3204e028a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548207, encodeId=c6b2154820e4f, content=<a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a>, objectTitle=无论年龄和性别，诺华靶向PCSK9的siRNA疗法均可在17个月内持续有效降低LDL-C, objectType=article, longId=203468, objectId=f49f20346875, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f49f20346875, replyNumber=0, likeNumber=118, createdTime=2020-11-18, rootId=0, userName=12498ebem23暂无昵称, userId=271114029857, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f49f20346875, moduleTitle=无论年龄和性别，诺华靶向PCSK9的siRNA疗法均可在17个月内持续有效降低LDL-C, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f49f20346875)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548206, encodeId=83aa154820658, content=<a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a>, objectTitle=Science Advances ：重大进展！薛雪/师冰洋/郑蒙开发新的递送方法，将siRNA递送至大脑治疗阿尔茨海默病, objectType=article, longId=202424, objectId=bfb0202424d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfb0202424d2, replyNumber=0, likeNumber=96, createdTime=2020-10-25, rootId=0, userName=12498ebem23暂无昵称, userId=271114029857, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfb0202424d2, moduleTitle=Science Advances ：重大进展！薛雪/师冰洋/郑蒙开发新的递送方法，将siRNA递送至大脑治疗阿尔茨海默病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfb0202424d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548205, encodeId=9180154820557, content=<a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a>, objectTitle=J Control Release：两亲性磷脂肽树状大分子纳米载体用于前列腺癌siRNA治疗 , objectType=article, longId=191983, objectId=d6d019198353, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6d019198353, replyNumber=0, likeNumber=0, createdTime=2020-04-12, rootId=0, userName=12498ebem23暂无昵称, userId=271114029857, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6d019198353, moduleTitle=J Control Release：两亲性磷脂肽树状大分子纳米载体用于前列腺癌siRNA治疗 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6d019198353)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548204, encodeId=11831548204ab, content=<a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a>, objectTitle=RNAi疗法对抗2019-nCoV：Sirnaomics推进基于RNAi的预防和治疗方法, objectType=article, longId=186736, objectId=d207186e36d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d207186e36d7, replyNumber=0, likeNumber=94, createdTime=2020-01-27, rootId=0, userName=12498ebem23暂无昵称, userId=271114029857, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d207186e36d7, moduleTitle=RNAi疗法对抗2019-nCoV：Sirnaomics推进基于RNAi的预防和治疗方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d207186e36d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548203, encodeId=8dd6154820304, content=<a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a>, objectTitle=诺华97亿收购的PCSK9的siRNA药物inclisiran，预计将于2020年批准上市, objectType=article, longId=185939, objectId=005818593917, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=005818593917, replyNumber=0, likeNumber=107, createdTime=2020-01-10, rootId=0, userName=12498ebem23暂无昵称, userId=271114029857, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=005818593917, moduleTitle=诺华97亿收购的PCSK9的siRNA药物inclisiran，预计将于2020年批准上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=005818593917)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548202, encodeId=5152154820267, content=<a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a>, objectTitle=诺华宣布以97亿美元收购The Medicines Company，同时获得PCSK9的siRNA抑制剂, objectType=article, longId=184019, objectId=daf618401931, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=daf618401931, replyNumber=0, likeNumber=0, createdTime=2019-12-04, rootId=0, userName=12498ebem23暂无昵称, userId=271114029857, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=daf618401931, moduleTitle=诺华宣布以97亿美元收购The Medicines Company，同时获得PCSK9的siRNA抑制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=daf618401931)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548201, encodeId=64e81548201d7, content=<a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a>, objectTitle=JCLA：siRNA靶向人喉鳞癌裸鼠模型中周骨骼肌苷的抑瘤作用, objectType=article, longId=166236, objectId=140c16623634, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=140c16623634, replyNumber=0, likeNumber=89, createdTime=2019-05-18, rootId=0, userName=12498ebem23暂无昵称, userId=271114029857, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=140c16623634, moduleTitle=JCLA：siRNA靶向人喉鳞癌裸鼠模型中周骨骼肌苷的抑瘤作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=140c16623634)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548200, encodeId=b502154820080, content=<a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a>, objectTitle=2019年AsiaTIDES：Sirnaomics将展示RNAi药物STP705在肝癌动物模型中的数据 , objectType=article, longId=161220, objectId=bd21161220d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd21161220d3, replyNumber=0, likeNumber=101, createdTime=2019-02-28, rootId=0, userName=12498ebem23暂无昵称, userId=271114029857, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd21161220d3, moduleTitle=2019年AsiaTIDES：Sirnaomics将展示RNAi药物STP705在肝癌动物模型中的数据 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd21161220d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548199, encodeId=2422154819996, content=<a href='/topic/show?id=c87e16332da' target=_blank style='color:#2F92EE;'>#siRNA#</a>, objectTitle=Biomaterials：可控制和持续递送siRNA/NP的水凝胶可有效加速骨折愈合, objectType=article, longId=149745, objectId=5f42149e45f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f42149e45f9, replyNumber=0, likeNumber=0, createdTime=2018-09-28, rootId=0, userName=12498ebem23暂无昵称, userId=271114029857, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f42149e45f9, moduleTitle=Biomaterials：可控制和持续递送siRNA/NP的水凝胶可有效加速骨折愈合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f42149e45f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

siRNA

2020-05-29

梅斯管理员

#siRNA# #慢性乙型肝炎#

GUT：香港大学袁孟峰团队报告了siRNA慢性乙型肝炎(CHB)感染患者中的治疗作用！

2024-09-16发表于上海

梅斯管理员

#血友病# #siRNA# #血浆纤溶酶原#

Sci Transl Med：革命性疗法：利用siRNA靶向减少血浆纤溶酶原，为血友病患者带来希望

2024-03-01发表于上海

梅斯管理员

前往app查看评论内容

2024-02-23发表于上海

梅斯管理员

#降脂药# #siRNA# #LDL-C#

新型长效降脂疗法，一次给药管半年！2024年共识：6条建议助力临床实践

2024-02-01发表于陕西省

梅斯管理员

#慢性粒细胞白血病# #siRNA# #BATF3#

Mol Biol Rep：siRNA介导的下调BATF3通过下调c-Myc表达降低慢性粒细胞白血病细胞的增殖和诱导凋亡

2024-01-14发表于上海

12498ebem23暂无昵称

#siRNA#

FDA批准vutrisiran治疗成人遗传性转甲状腺素蛋白淀粉样变性伴多发性神经病（hATTR-PN），这是第5款siRNA药物

2022-06-18

12498ebem23暂无昵称

#siRNA#

JAMA：这一增加6成中风风险的坏“血脂”，终于有针对它的siRNA可以用了！

2022-04-07

12498ebem23暂无昵称

#siRNA#

EHJ重磅：siRNA皮下注射有望长效降脂，长命百岁将不再是梦！

2022-03-19

12498ebem23暂无昵称

#siRNA#

STTT：治愈乙肝新希望：新型纳米载体，递送siRNA特异性靶向肝细胞

2022-02-23

12498ebem23暂无昵称

#siRNA#

今日探报 | 诺华长效降脂siRNA疗法获FDA批准上市；研究表明，利用一滴血或许就能快速检测出早期肺癌……

2021-12-29

12498ebem23暂无昵称

#siRNA#

美国FDA延迟批准诺华的siRNA药物inclisiran

2020-12-21

12498ebem23暂无昵称

#siRNA#

无论年龄和性别，诺华靶向PCSK9的siRNA疗法均可在17个月内持续有效降低LDL-C

2020-11-18

12498ebem23暂无昵称

#siRNA#

Science Advances ：重大进展！薛雪/师冰洋/郑蒙开发新的递送方法，将siRNA递送至大脑治疗阿尔茨海默病

2020-10-25

12498ebem23暂无昵称

#siRNA#

J Control Release：两亲性磷脂肽树状大分子纳米载体用于前列腺癌siRNA治疗

2020-04-12

12498ebem23暂无昵称

#siRNA#

RNAi疗法对抗2019-nCoV：Sirnaomics推进基于RNAi的预防和治疗方法

2020-01-27

12498ebem23暂无昵称

#siRNA#

诺华97亿收购的PCSK9的siRNA药物inclisiran，预计将于2020年批准上市

2020-01-10

12498ebem23暂无昵称

#siRNA#

诺华宣布以97亿美元收购The Medicines Company，同时获得PCSK9的siRNA抑制剂

2019-12-04

12498ebem23暂无昵称

#siRNA#

JCLA：siRNA靶向人喉鳞癌裸鼠模型中周骨骼肌苷的抑瘤作用

2019-05-18

12498ebem23暂无昵称

#siRNA#

2019年AsiaTIDES：Sirnaomics将展示RNAi药物STP705在肝癌动物模型中的数据 

2019-02-28

12498ebem23暂无昵称

#siRNA#

Biomaterials：可控制和持续递送siRNA/NP的水凝胶可有效加速骨折愈合

2018-09-28

科室
- - 订阅+
  - 更多科室
工具
服务